Free Trial
→ The Iran War Just Broke the Gold Market (From Behind the Markets) (Ad)tc pixel Free IPX Stock Alerts

IperionX (IPX) Financials

IperionX logo
$37.75 +3.93 (+11.62%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$37.37 -0.38 (-1.00%)
As of 04:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for IperionX

Annual Income Statements for IperionX

This table shows IperionX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -44 -35 -44 -72
Consolidated Net Income / (Loss)		 -22 -17 -22 -35
Net Income / (Loss) Continuing Operations		 -22 -17 -22 -35
Total Pre-Tax Income 		-22 -17 -22 -35
Total Operating Income		 -22 -17 -22 -35
Total Gross Profit		 -7.99 -2.18 -3.43 -6.32
Total Revenue		 0.40 0.49 0.55 3.55
Operating Revenue		 0.40 0.49 0.55 3.55
Total Cost of Revenue		 8.39 2.68 3.98 9.87
Operating Cost of Revenue		 8.39 2.68 3.98 9.87
Total Operating Expenses		 14 15 18 29
Selling, General & Admin Expense		 3.06 3.99 4.52 11
Research & Development Expense		 4.28 8.26 12 16
Exploration Expense		 6.19 2.83 1.95 2.89
Other Operating Expenses / (Income)		 0.00 0.19 -0.41 -0.68
Total Other Income / (Expense), net		 0.00 0.00 0.00 0.00
Income Tax Expense		 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.16) ($0.11) ($0.10) ($0.12)
Weighted Average Basic Shares Outstanding		 - - 257.24M 319.93M
Diluted Earnings per Share		 ($0.16) ($0.11) ($0.10) ($0.12)
Weighted Average Diluted Shares Outstanding		 - - 257.24M 319.93M
Weighted Average Basic & Diluted Shares Outstanding		 - - 257.24M 319.93M

Quarterly Income Statements for IperionX

No quarterly income statements for IperionX are available.

Annual Cash Flow Statements for IperionX

This table details how cash moves in and out of IperionX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents		 21 32 62 74
Net Cash From Operating Activities		 3.78 4.95 23 22
Net Cash From Continuing Operating Activities		 3.78 4.95 23 22
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income		 -0.43 -1.51 0.72 -2.61
Changes in Operating Assets and Liabilities, net		 4.22 6.46 22 24
Net Cash From Investing Activities		 -2.82 -2.71 -8.07 -18
Net Cash From Continuing Investing Activities		 -2.82 -2.71 -8.07 -18
Purchase of Property, Plant & Equipment		 -0.89 -2.08 -5.02 -17
Sale of Property, Plant & Equipment		 -1.93 -0.63 -3.05 -0.64
Net Cash From Financing Activities		 20 29 48 71
Net Cash From Continuing Financing Activities		 20 29 48 71
Repayment of Debt		 -0.00 -0.01 -0.01 -0.01
Issuance of Common Equity		 20 30 48 71
Other Financing Activities, net		 -0.08 -0.51 -0.42 -0.51
Other Net Changes in Cash		 -0.22 -0.06 -0.24 -0.26

Quarterly Cash Flow Statements for IperionX

No quarterly cash flow statements for IperionX are available.

Annual Balance Sheets for IperionX

This table presents IperionX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 6/30/2023 6/30/2024 6/30/2025
Total Assets		 23 55 105
Total Current Assets		 13 42 59
Cash & Equivalents		 12 33 55
Accounts Receivable		 0.23 2.30 0.82
Inventories, net		 0.00 0.02 0.00
Prepaid Expenses		 0.59 6.07 3.24
Plant, Property, & Equipment, net		 3.99 7.77 25
Plant, Property & Equipment, gross		 3.99 7.77 25
Total Noncurrent Assets		 6.06 6.11 21
Intangible Assets		 - 0.00 14
Other Noncurrent Operating Assets		 6.06 6.11 7.41
Total Liabilities & Shareholders' Equity		 23 55 105
Total Liabilities		 2.24 4.10 13
Total Current Liabilities		 1.65 3.05 8.43
Short-Term Debt		 0.38 0.45 0.47
Accounts Payable		 1.18 2.32 7.49
Other Current Liabilities		 0.08 0.29 0.47
Total Noncurrent Liabilities		 0.59 1.04 4.16
Long-Term Debt		 0.59 1.04 3.46
Other Noncurrent Operating Liabilities		 - 0.00 0.70
Total Equity & Noncontrolling Interests		 21 51 92
Total Preferred & Common Equity		 21 51 92
Total Common Equity		 21 51 92
Common Stock		 59 113 198
Retained Earnings		 -52 -74 -109
Other Equity Adjustments		 14 12 3.69

Quarterly Balance Sheets for IperionX

No quarterly balance sheets for IperionX are available.

Annual Metrics And Ratios for IperionX

This table displays calculated financial ratios and metrics derived from IperionX's official financial filings.

Metric 2022 2023 2024 2025
Period end date 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Growth Metrics		 - - - -
Revenue Growth		 0.00% 23.30% 10.43% 550.26%
EBITDA Growth		 0.00% 18.94% -25.22% -61.83%
EBIT Growth		 0.00% 18.94% -25.22% -61.83%
NOPAT Growth		 0.00% 18.94% -25.22% -61.83%
Net Income Growth		 0.00% 18.94% -25.22% -61.83%
EPS Growth		 0.00% 31.25% 9.09% -20.00%
Operating Cash Flow Growth		 0.00% 30.81% 359.02% -5.33%
Free Cash Flow Firm Growth		 0.00% 0.00% -16.28% -83.87%
Invested Capital Growth		 0.00% 0.00% 104.91% 111.28%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - -
Gross Margin		 -1,992.68% -441.50% -628.65% -178.10%
EBITDA Margin		 -5,366.29% -3,527.98% -4,000.46% -995.56%
Operating Margin		 -5,366.29% -3,527.98% -4,000.46% -995.56%
EBIT Margin		 -5,366.29% -3,527.98% -4,000.46% -995.56%
Profit (Net Income) Margin		 -5,366.29% -3,527.98% -4,000.46% -995.56%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -254.39% -104.47% -80.81%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -158.91% -73.72% -55.12%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 84.72% 43.71% 31.64%
Return on Equity (ROE)		 0.00% -169.67% -60.76% -49.17%
Cash Return on Invested Capital (CROIC)		 0.00% -454.39% -173.28% -152.31%
Operating Return on Assets (OROA)		 0.00% -76.50% -55.84% -44.06%
Return on Assets (ROA)		 0.00% -76.50% -55.84% -44.06%
Return on Common Equity (ROCE)		 0.00% -169.67% -60.76% -49.17%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -84.83% -42.55% 0.00%
Net Operating Profit after Tax (NOPAT)		 -15 -12 -15 -25
NOPAT Margin		 -3,756.40% -2,469.58% -2,800.32% -696.89%
Net Nonoperating Expense Percent (NNEP)		 0.00% -95.48% -30.74% -25.69%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -25.67%
Cost of Revenue to Revenue		 2,092.68% 541.50% 728.65% 278.10%
SG&A Expenses to Revenue		 762.07% 807.06% 827.13% 300.97%
R&D to Revenue		 1,068.28% 1,669.48% 2,263.39% 454.09%
Operating Expenses to Revenue		 3,373.61% 3,086.48% 3,371.80% 817.46%
Earnings before Interest and Taxes (EBIT)		 -22 -17 -22 -35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -22 -17 -22 -35
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.05 0.03 0.04
Long-Term Debt to Equity		 0.00 0.03 0.02 0.04
Financial Leverage		 0.00 -0.53 -0.59 -0.57
Leverage Ratio		 0.00 1.11 1.09 1.12
Compound Leverage Factor		 0.00 1.11 1.09 1.12
Debt to Total Capital		 0.00% 4.53% 2.82% 4.08%
Short-Term Debt to Total Capital		 0.00% 1.78% 0.84% 0.49%
Long-Term Debt to Total Capital		 0.00% 2.75% 1.98% 3.59%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 95.47% 97.18% 95.92%
Debt to EBITDA		 0.00 -0.06 -0.07 -0.11
Net Debt to EBITDA		 0.00 0.63 1.45 1.44
Long-Term Debt to EBITDA		 0.00 -0.03 -0.05 -0.10
Debt to NOPAT		 0.00 -0.08 -0.10 -0.16
Net Debt to NOPAT		 0.00 0.90 2.07 2.06
Long-Term Debt to NOPAT		 0.00 -0.05 -0.07 -0.14
Altman Z-Score		 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 0.00 7.74 13.62 6.99
Quick Ratio		 0.00 7.38 11.62 6.60
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -22 -25 -47
Operating Cash Flow to CapEx		 134.38% 182.99% 281.62% 122.18%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.00 0.02 0.01 0.04
Accounts Receivable Turnover		 0.00 2.17 0.43 2.27
Inventory Turnover		 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.12 0.09 0.22
Accounts Payable Turnover		 0.00 2.27 2.27 2.01
Days Sales Outstanding (DSO)		 0.00 168.59 845.74 160.64
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 160.99 160.49 181.26
Cash Conversion Cycle (CCC)		 0.00 7.60 685.25 -20.62
Capital & Investment Metrics		 - - - -
Invested Capital		 0.00 9.60 20 42
Invested Capital Turnover		 0.00 0.10 0.04 0.12
Increase / (Decrease) in Invested Capital		 0.00 9.60 10 22
Enterprise Value (EV)		 0.00 0.00 0.00 0.00
Market Capitalization		 0.00 0.00 0.00 0.00
Book Value per Share		 $0.00 $0.00 $0.20 $0.36
Tangible Book Value per Share		 $0.00 $0.00 $0.20 $0.31
Total Capital		 0.00 22 53 96
Total Debt		 0.00 0.98 1.49 3.93
Total Long-Term Debt		 0.00 0.59 1.04 3.46
Net Debt		 0.00 -11 -32 -51
Capital Expenditures (CapEx)		 2.82 2.71 8.07 18
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -0.45 5.79 -3.89
Debt-free Net Working Capital (DFNWC)		 0.00 11 39 51
Net Working Capital (NWC)		 0.00 11 38 50
Net Nonoperating Expense (NNE)		 6.46 5.23 6.55 11
Net Nonoperating Obligations (NNO)		 0.00 -11 -32 -51
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -90.64% 1,059.47% -109.68%
Debt-free Net Working Capital to Revenue		 0.00% 2,323.65% 7,131.93% 1,434.11%
Net Working Capital to Revenue		 0.00% 2,246.27% 7,050.29% 1,420.81%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.10) ($0.12)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 257.24M 319.93M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.10) ($0.12)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 257.24M 319.93M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 257.24M 319.93M
Normalized Net Operating Profit after Tax (NOPAT)		 -15 -12 -15 -25
Normalized NOPAT Margin		 -3,756.40% -2,469.58% -2,800.32% -696.89%
Pre Tax Income Margin		 -5,366.29% -3,527.98% -4,000.46% -995.56%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for IperionX

No quarterly metrics and ratios for IperionX are available.


Financials Breakdown Chart

Frequently Asked Questions About IperionX's Financials

When does IperionX's fiscal year end?

According to the most recent income statement we have on file, IperionX's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

How has IperionX's net income changed over the last 3 years?

IperionX's net income appears to be on an upward trend, with a most recent value of -$35.35 million in 2025, rising from -$21.52 million in 2022. The previous period was -$21.84 million in 2024. See IperionX's forecast for analyst expectations on what’s next for the company.

What is IperionX's operating income?
IperionX's total operating income in 2025 was -$35.35 million, based on the following breakdown:
  • Total Gross Profit: -$6.32 million
  • Total Operating Expenses: $29.02 million
How has IperionX's revenue changed over the last 3 years?

Over the last 3 years, IperionX's total revenue changed from $401.05 thousand in 2022 to $3.55 million in 2025, a change of 785.3%.

How much debt does IperionX have?

IperionX's total liabilities were at $12.59 million at the end of 2025, a 207.4% increase from 2024, and a 462.0% increase since 2023.

How much cash does IperionX have?

In the past 2 years, IperionX's cash and equivalents has ranged from $11.94 million in 2023 to $54.81 million in 2025, and is currently $54.81 million as of their latest financial filing in 2025.

How has IperionX's book value per share changed over the last 3 years?

Over the last 3 years, IperionX's book value per share changed from 0.00 in 2022 to 0.36 in 2025, a change of 35.9%.


Related Companies

Financial statements for NASDAQ:IPX last updated on 11/14/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
The $1.75T "Backdoor" ticker (NOT Starlink)
When the SpaceX IPO launches, most investors will already be too late. The real opportunity isn't the IPO itse...
Behind the Markets | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel